Fig. 3
From: Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS
Intravascular thrombin/fibrin formation pathway and related anti-thrombolytic therapy. *Created with BioRender.com
Fig. 3 | Journal of Intensive Care